Obesity is associated with greater risk for unfavourable pathological features in men with low risk prostate cancer who are eligible for active surveillance, according to a study. Obese men are likely to have transition zone cancer, which is related to unfavourable pathology findings in those with very low risk prostate cancer.
The intravesical installation of Bacillus Calmette-Guerin (BCG) and mitomycin C (MMC) is a safe and effective approach to nonmuscle-invasive bladder cancer (NMIBC) following transurethral resection (TUR), a new systematic review shows.
A 2-week spa therapy including adapted physical activity and nutritional education performed shortly after chemotherapy affords durable quality of life (QoL) improvements, as well as weight reduction, in breast cancer patients, a study has shown.
No association exists between blood pressure (BP) and breast cancer, according to a recent study, supporting the findings of previous studies. The conclusions reached are similar when evaluating BP over time and when assessing specific tumour subtypes.
Colorectal cancer is one of the leading cancers worldwide and one of the most difficult to treat because patients often present in later, metastatic stages of disease. Preventing blood vessel growth is a popular therapeutic strategy to help reduce the proliferation of cancerous tissue. Aflibercept (Zaltrap®, Sanofi) is a monoclonal antibody treatment that targets the cell signalling pathways of angiogenesis to prevent blood vessel growth in malignancies.
Genetically engineered T cells that target and destroy plasma cells may have the potential to cure patients with advanced multiple myeloma (MM), according to the results of a small, phase I/II trial in which one patient with over 90 percent of bone marrow cells affected was cleared of myeloma 1 month after treatment and researchers say he remains in stringent complete remission. [ASH 2015, abstract LBA 1]